We are live on ! Find out more
GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

94 hedge funds and large institutions have $863M invested in G1 Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 43 increasing their positions, 21 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 21

89% more capital invested

Capital invested by funds: $457M → $863M (+$406M)

64% more call options, than puts

Call options by funds: $401K | Put options by funds: $245K

29% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 14

1% more funds holding

Funds holding: 93 → 94 (+1)

Holders
94
Holders Change
+1
Holders Change %
+1.08%
% of All Funds
2.04%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
18
Increased
43
Reduced
21
Closed
14
Calls
$401K
Puts
$245K
Net Calls
+$156K
Net Calls Change
+$151K

Top Buyers

Rank Fund Capital Flow
1
BG
Bellevue Group
Switzerland
+$14.1M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$11.5M
3
BlackRock
BlackRock
New York
+$11.2M
4
JP Morgan Chase
JP Morgan Chase
New York
+$6.54M
5
RG
Redmile Group
California
+$6.16M

Top Sellers

Rank Fund Capital Flow
1
Bank of New York Mellon
Bank of New York Mellon
New York
-$20.6M
2
Morgan Stanley
Morgan Stanley
New York
-$7.19M
3
Citadel Advisors
Citadel Advisors
Florida
-$5.38M
4
VOYA Investment Management
VOYA Investment Management
Georgia
-$3.63M
5
Deutsche Bank
Deutsche Bank
Germany
-$3.55M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$3.94M -$499K -23,714 -16%
BBA
27
Baker Bros. Advisors
New York
$3.9M – – –
Goldman Sachs
28
Goldman Sachs
New York
$3.83M +$205K +9,746 +8%
N
29
Nuveen
North Carolina
$3.5M +$2.41M +114,328 New
USAA
30
United Services Automobile Association
Texas
$2.88M +$244K +11,600 +14%
AA
31
ALPS Advisors
Colorado
$2.4M -$240K -11,404 -13%
Ameriprise
32
Ameriprise
Minnesota
$2.36M +$328K +15,562 +25%
Rafferty Asset Management
33
Rafferty Asset Management
New York
$1.76M +$37.5K +1,782 +3%
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$1.6M +$346K +16,424 +46%
Allianz Asset Management
35
Allianz Asset Management
Germany
$1.54M +$313K +14,866 +42%
Swiss National Bank
36
Swiss National Bank
Switzerland
$1.48M +$90.5K +4,300 +10%
AllianceBernstein
37
AllianceBernstein
Tennessee
$1.46M +$440K +20,900 +79%
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$1.35M +$300K +14,241 +48%
EGI
39
EAM Global Investors
California
$1.34M +$918K +43,584 New
BC
40
Birchview Capital
Vermont
$1.23M +$526K +25,000 +167%
Invesco
41
Invesco
Georgia
$1.21M -$653K -31,001 -44%
S
42
SignatureFD
Georgia
$1.16M – – –
BWA
43
BDO Wealth Advisors
Florida
$1.08M – – –
BFM
44
Boothbay Fund Management
New York
$1.08M +$739K +35,111 New
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$1.07M +$738K +35,037 New
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$1.06M +$299K +14,200 +69%
EI
47
EAM Investors
California
$1.03M +$711K +33,771 New
TD Asset Management
48
TD Asset Management
Ontario, Canada
$1.01M -$209K -9,941 -23%
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$966K -$34.2K -1,626 -5%
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$950K +$14.7K +700 +2%
1
2
3 4 5

GTHX Hedge Fund Activity: Q2 2019 in Review

94 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in G1 Therapeutics, Inc. Common Stock (GTHX) for Q2 2019, worth a combined $863M — up 89% from $457M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new GTHX positions and 14 closed out — a net gain of 4 holders — while 43 added to existing stakes and 21 trimmed.

The largest buyer was Bellevue Group, opening a new position worth an estimated $14.1M. The largest seller was Bank of New York Mellon, cutting an estimated $20.6M.

  • 94 institutional investors held G1 Therapeutics, Inc. Common Stock (GTHX) as of Q2 2019, up from 93 in Q1 2019.
  • Funds reported $863M of G1 Therapeutics, Inc. Common Stock stock for Q2 2019, up 89% quarter-over-quarter.
  • 18 funds opened new G1 Therapeutics, Inc. Common Stock positions in Q2 2019 and 14 closed out, a net change of +4 holders.
  • The largest G1 Therapeutics, Inc. Common Stock buyer in Q2 2019 was Bellevue Group, an estimated $14.1M added.
  • The largest G1 Therapeutics, Inc. Common Stock seller in Q2 2019 was Bank of New York Mellon, an estimated $20.6M sold.

Based on aggregated 13F filings for Q2 2019.